_1611126445 1611126445 Editor editor.jddt@gmail.com Universal Journal of Pharmaceutical Research Universal Journal of Pharmaceutical Research Univ J Pharm Res 2456-8058 01 15 2021 Mai ES. Ghoneim Asmaa A. Khalifa https://orcid.org/0000-0002-1453-1991 Bassma M. Ali By the end of 2019, SARS-CoV-2, a new virus from Coronaviruses family,  has been detected in China and was responsible for COVID-19 disease.  This disease has been suddenly and vigorously disseminated among individuals all over the world. Based on genetic vicinity, this novel virus is similar to SARS-CoV and MERS-CoV; it can spread from an unknown animal host to individuals. Till now, there is no specific therapy or vaccine for the treatment of COVID-19 patients. However, published clinical data and in vitro studies may offer treatment strategies of some effective antiviral and repurposed drugs, including remdesivir, favipiravir, lopinavir/ritonavir, corticosteroids, etc. This narrative review describes current pharmacological proposed treatments for COVID-19 patients and available experimental and clinical studies for these drugs. Eventually, these data may help to explain the most preferable way to treat COVID-19 and lessen symptoms and complications accompanied with it.                                 Peer Review History: Received 6 November  2020; Revised 25 Decembe; Accepted 4 January, Available online 15 January 2021 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. Received file:                           Comments of reviewer(s):         Average Peer review marks at initial stage: 5.5/10 Average Peer review marks at publication stage: 7.5/10 Reviewer(s) detail: Dr. DANIYAN Oluwatoyin Michael, Obafemi Awolowo University, ILE-IFE, Nigeria, toyinpharm@gmail.com Dr. George Zhu, Tehran University of Medical Sciences, Tehran, Iran, sansan4240732@163.com Dr. Nuray Arı, Ankara University, Turkiye, ari@ankara.edu.tr Similar Articles: USE OF COLCHICINE TO COUNTERACT THE STRONG HYPERINFLAMMATORY STATE INDUCED BY SARS-COV-2 THE RISKS AND ADVANTAGES OF ANTI-DIABETES THERAPY IN THE POSITIVE COVID-19 PATIENT EUCALYPTUS ESSENTIAL OIL; AN OFF-LABEL USE TO PROTECT THE WORLD FROM COVID-19 PANDEMIC: REVIEW-BASED HYPOTHESES SUDANESE EXPERIENCE OF HERBAL FORMULAS USED DURING COVID-19 INFECTION TRADITIONAL TO RECENT APPROACHES IN HERBAL MEDICINE THERAPY OF COVID-19   01 15 2021 10.22270/ujpr.v5i6.514 http://ujpr.org/index.php/journal/article/view/514 http://ujpr.org/index.php/journal/article/download/514/865 http://ujpr.org/index.php/journal/article/download/514/878 http://ujpr.org/index.php/journal/article/download/514/890 http://ujpr.org/index.php/journal/article/download/514/865 http://ujpr.org/index.php/journal/article/download/514/878 http://ujpr.org/index.php/journal/article/download/514/890